RIGL
Rigel Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $532.56M | Price | $31.58 |
| Volume | 473.41K | Change | -0.13% |
| P/E Ratio | 30.5 | Open | $32.00 |
| Revenue | $179.3M | Prev Close | $31.62 |
| Net Income | $17.5M | 52W Range | $13.91 - $43.72 |
| Div Yield | N/A | Target | $41.20 |
| Overall | 70 | Value | 80 |
| Quality | 52 | Technical | 80 |
No chart data available
Stock Overview
Updated DailyRigel Pharmaceuticals Inc. (RIGL) is a leading Healthcare company in the Biotechnology industry, currently trading at $31.58 with a market capitalization of $532.56 million. The stock is trading in the middle of its 52-week range, demonstrating average quality indicators with a MarketXLS quality score of 52.
Today's trading session shows RIGL with a volume of 473K shares. The stock opened up 1.20% from yesterday's close of $31.62. Current analyst estimates project earnings of $5.49 per share for this year, with next year targeting $3.53.
RIGL demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including CCXI, AZN, SGMO, INFI, THRX.
Key investment considerations for RIGL include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 30.5%. The stock shows attractive valuation opportunity based on valuation analysis.
Analysis generated on November 3, 2025 at 07:17 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RIGL | $31.58 | -0.1% | 473.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Rigel Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW